Web Analytics

Investor Profile

Oxford Science Enterprises

Oxford Science Enterprises United Kingdom - Oxford, England
INVESTOR

1 Disclosed Funding Rounds $85,000,000
48 Participating Investments




Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the

Invested In

Company Date Round Raised
  Mixergy Ltd March, 28 ,2023 Unknown $11,326,000
  BibliU June, 09 ,2022 Series B $15,000,000
  Osler Diagnostics November, 07 ,2022 Series C $85,000,000
  Caristo Diagnostics April, 18 ,2023 Series A $16,300,000
  Oxford Ionics January, 12 ,2023 Series A $36,500,000
  PQShield January, 26 ,2022 Series A $20,000,000
  Salience Labs May, 12 ,2022 Seed $11,500,000
  Prolific July, 14 ,2023 Unknown $32,764,500
  BibliU June, 09 ,2022 Series B $15,000,000
  Mixergy Ltd March, 28 ,2023 Unknown $11,326,000
  Caristo Diagnostics April, 18 ,2023 Series A $16,300,000
  Salience Labs May, 12 ,2022 Seed $11,500,000
  AlveoGene September, 15 ,2023 Seed
  PQShield January, 26 ,2022 Series A $20,000,000
  Prolific July, 14 ,2023 Unknown $32,764,500
  Mixergy Ltd March, 28 ,2023 Unknown $11,326,000
  Navenio September, 21 ,2023 Unknown $6,300,000
  Caristo Diagnostics April, 18 ,2023 Series A $16,300,000
  AlveoGene September, 15 ,2023 Seed
  PQShield January, 26 ,2022 Series A $20,000,000
  Sitryx September, 28 ,2023 Unknown $39,500,000
  Prolific July, 14 ,2023 Unknown $32,764,500
  Navenio September, 21 ,2023 Unknown $6,300,000
  Caristo Diagnostics April, 18 ,2023 Series A $16,300,000
  Oxford Quantum Circuits November, 28 ,2023 Unknown $100,000,000
  AlveoGene September, 15 ,2023 Seed
  Sitryx September, 28 ,2023 Unknown $39,500,000
  Prolific July, 14 ,2023 Unknown $32,764,500
  Grey Wolf Therapeutics May, 23 ,2024 Series B $50,000,000
  Navenio September, 21 ,2023 Unknown $6,300,000
  Oxford Quantum Circuits November, 28 ,2023 Unknown $100,000,000
  AlveoGene September, 15 ,2023 Seed
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000
  Sitryx September, 28 ,2023 Unknown $39,500,000
  Grey Wolf Therapeutics May, 23 ,2024 Series B $50,000,000
  Navenio September, 21 ,2023 Unknown $6,300,000
  Oxford Quantum Circuits November, 28 ,2023 Unknown $100,000,000
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000
  Sitryx September, 28 ,2023 Unknown $39,500,000
  Fractile July, 26 ,2024 Seed $15,000,000
  Grey Wolf Therapeutics May, 23 ,2024 Series B $50,000,000
  Alloyed March, 18 ,2025 Series B $47,989,925
  Oxford Quantum Circuits November, 28 ,2023 Unknown $100,000,000
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000
  Grey Wolf Therapeutics May, 23 ,2024 Series B $50,000,000
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000
  Fractile July, 26 ,2024 Seed $15,000,000
  Alloyed March, 18 ,2025 Series B $47,989,925